doi: 10.1136/bmj.297.6660.1392.
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: reduces morbidity in a significant minority of patients
Affiliations
- PMID: 2905897
- PMCID: PMC1835100
- DOI: 10.1136/bmj.297.6660.1392
Item in Clipboard
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: reduces morbidity in a significant minority of patients
BMJ.
.
No abstract available
Similar articles
-
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.BMJ. 1988 Nov 26;297(6660):1393-4. doi: 10.1136/bmj.297.6660.1393. BMJ. 1988. PMID: 2905898 Free PMC article.
-
[Prevention of recurrence of peptic ulcers].Verh Dtsch Ges Inn Med. 1989;95:319-22. Verh Dtsch Ges Inn Med. 1989. PMID: 2574921 Review. German. No abstract available.
-
Editorial: Histamine antagonists and peptic ulcer.Br Med J. 1976 Apr 3;1(6013):789-90. doi: 10.1136/bmj.1.6013.789. Br Med J. 1976. PMID: 4195 Free PMC article. No abstract available.
-
[H1 and H2 histamine antagonists. Principles and rules of use].Rev Prat. 1996 Jun 15;46(12):1547-50. Rev Prat. 1996. PMID: 8881170 French. No abstract available.
-
[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].Wien Med Wochenschr. 1983;133(4-5):104-7. Wien Med Wochenschr. 1983. PMID: 6134397 Review. German. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical